OpGen
OPGN
$0.51
Share price
-3.21%
Change (1 day)
-37.96%
Change (1 year)
Categories
OpGen (OPGN) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $15.45 M
According to OpGen 's latest financial reports the company's total liabilities are $15.45 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
OpGen - Total liabilities on balance sheet (from 2014 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $18.23 M | -40.11% |
| 2021-12-31 | $30.44 M | 6.62% |
| 2020-12-31 | $28.55 M | 366.02% |
| 2019-12-31 | $6.12 M | 8.63% |
| 2018-12-31 | $5.64 M | 8.1% |
| 2017-12-31 | $5.21 M | -10.27% |
| 2016-12-31 | $5.81 M | -7.16% |
| 2015-12-31 | $6.26 M | -41.56% |
| 2014-12-31 | $10.72 M | 114.83% |
| 2013-12-31 | $4.99 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.13 B | 786.06% | 🇺🇸 USA |
 Enzo Biochem ENZ | $28.3 M | 83.09% | 🇺🇸 USA |